SLG
WST icon

Stanley-Laman Group’s West Pharmaceutical WST Stock Holding History

Stanley-Laman Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-792
Closed -$325K – 312
2022
Q1 		$325K Sell
792
-1,141
-59% -$447K 0.05% 225
2021
Q4 		$907K Hold
1,933
– – 0.11% 205
2021
Q3 		$821K Hold
1,933
– – 0.11% 201
2021
Q2 		$694K Sell
1,933
-15
-0.8% -$4.96K 0.1% 204
2021
Q1 		$549K Buy
1,948
+50
+3% +$14.3K 0.09% 206
2020
Q4 		$538K Buy
1,898
+293
+18% +$82.2K 0.1% 202
2020
Q3 		$441K Hold
1,605
– – 0.1% 185
2020
Q2 		$365K Hold
1,605
– – 0.09% 201
2020
Q1 		$244K Buy
+1,605
New +$247K 0.07% 223

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return